HKBU researcher awarded Chinese Medicine Development Fund (CMDF) from the Health Bureau

We are elated to announce that Dr Chan Kam Wa, Assistant Professor from the School of Chinese Medicine, has recently been awarded an impressive HK$2 million, the maximum amount from the Chinese Medicine Applied Studies and Research Funding Scheme (B2) under CMDF.

Dr Chan’s awarded project is entitled “代謝類疾病證候特點及中醫療效前瞻觀察性先導研究”. His research team members include Professor Li Min, Executive Associate Dean of Chinese Medicine and Ma Pak Leung Endowed Professor in Innovative Neuromedicine and Dr Lyu Haitao from the School of Chinese Medicine, and Professor Huang Xianzhang of the Guangzhou University of Chinese Medicine. The project aims to obtain epidemiological data on a range of metabolic diseases by analysing the clinical presentation of patients and reviewing relevant literature. The project will provide evidence for the development of clinical diagnosis, research and guidelines of metabolic diseases as a cluster, and enhance the communication between Chinese and Western medicine. The data on the efficacy of Chinese medicine treatments derived from the project can also aid in clinical diagnosis and guide the design of further randomised controlled trials.

Established in 2019, CMDF was supervised by the Chinese Medicine Unit of the Health Bureau and implemented by the Hong Kong Productivity Council. The Fund is comprised of the Enterprise Support Programme (ESP) and Industry Support Programme (ISP), which are dedicated to nurturing talents, enhancing facilities and services, promoting Chinese medicine culture and concepts, and promoting applied studies and research on Chinese medicine. Practitioners, organisations and stakeholders in the Chinese medicine sector have benefited from the Fund.

We extend our heartfelt congratulations to Dr Chan on receiving a substantial grant for his remarkable project, which promises to propel the field of Chinese medicine research into exciting new frontiers.